TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING AWARENESS OF BLUE BIOTECHNOLOGY-BASED NUTRACEUTICALS AND PHARMACEUTICALS
4.2.2 RISING STRATEGIC INITIATIVES ASSOCIATED WITH PHARMACEUTICALS AND NUTRACEUTICALS SOURCED FROM MARINE ORGANISMS
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY POLICIES
4.4 OPPORTUNITIES
4.4.1 INCREASING INVESTMENT IN THE DEVELOPMENT OF BIOTECHNOLOGY-BASED MEDICINE
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE INDIA CELL CULTURE MEDIA MARKET
5.2.1 IMPACT ON SUPPLY CHAIN
6 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 ENZYMES
6.3 PHARMA PRODUCTS
6.4 BULK CHEMICALS
6.5 BIOPOLYMERS
6.6 OTHERS
7 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 BIOENGINEERING
7.3 GENOMICS
7.4 VACCINE DEVELOPMENT
7.5 DRUG DISCOVERY
7.6 FISHERIES
7.7 AQUACULTURE
7.8 BIOFUELS
7.9 WATER TREATMENT SERVICES
7.10 OTHERS
8 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 PHARMACEUTICAL COMPANIES
8.4 BIOTECHNOLOGY COMPANIES
8.5 OTHERS
9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 NORWAY
9.3.7 NETHERLANDS
9.3.8 SWITZERLAND
9.3.9 FINLAND
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST
9.5.3 AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE BLUE BIOTECHNOLOGY MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE BLUE BIOTECHNOLOGY MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT LAUNCH / PRODUCT APPROVAL
10.6.2 AGREEMENT
10.6.3 PARTNERSHIP
10.6.4 ACQUISITION
10.7 MAJOR PLAYERS FINANCIAL
10.7.1 SALES (USD MILLION), 2023
10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2023
11 COMPANY PROFILES
11.1 MARINOMED BIOTECH AG
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIES
11.2 MARSHALL MARINE PRODUCTS/
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIES
11.3 MARINOVA
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 AKER BIOMARINE
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 PHARMAMAR
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 CYANOTECH CORPORATION
11.6.1 COMPANY OVERVIEWS
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 ADM
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL ANALYSIS
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 GEOMARINE BIOTECHNOLOGIES
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 CP KELCO U.S., INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCT OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 TERSERA THERAPEUTICS LLC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR ENZYMES, BY REGION, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMA PRODUCTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 6 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BULK CHEMICALS, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOPOLYMERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOENGINEERING, BY REGION, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR GENOMICS, BY REGION, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR VACCINE DEVELOPMENT, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR DRUG DISCOVERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR FISHERIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR AQUACULTURE, BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOFUELS, BY REGION, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR WATER TREATMENT SERVICES, BY REGION, 2019–2032 (USD MILLION)
TABLE 18 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 19 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 20 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION)
TABLE 21 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 22 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 23 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 24 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 25 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 26 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 27 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 28 US: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 29 US: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 30 US: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 31 CANADA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 32 CANADA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 33 CANADA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 34 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 35 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 36 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 37 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 38 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 39 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 40 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 41 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 42 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 43 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 44 UK: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 45 UK: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 46 UK: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 47 ITALY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 48 ITALY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 49 ITALY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 50 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 51 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 52 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 53 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 54 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 55 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 56 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 57 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 58 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 59 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 60 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 61 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 62 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 63 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 64 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 65 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 66 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 67 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 68 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 69 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 70 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 71 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 72 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 73 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 74 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 75 CHINA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 76 CHINA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 77 CHINA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 78 INDIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 79 INDIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 80 INDIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 81 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 82 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 83 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 84 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 85 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 86 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 87 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 88 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 89 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 90 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 91 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 92 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 94 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 95 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 96 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 97 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 98 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 99 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 100 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 101 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 102 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 103 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 104 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 105 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 106 MAJOR PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
TABLE 107 MOST ACTIVE PLAYER IN THE BLUE BIOTECHNOLOGY MARKET
TABLE 108 PRODUCT LAUNCH / PRODUCT APPROVAL
TABLE 109 AGREEMENT
TABLE 110 PARTNERSHIP
TABLE 111 ACQUISITION
TABLE 112 MARINOMED BIOTECH AG: PRODUCTS OFFERED
TABLE 113 MARINOMED BIOTECH AG: KEY DEVELOPMENTS
TABLE 114 MARSHALL MARINE PRODUCTS: PRODUCTS OFFERED
TABLE 115 MARINOVA: PRODUCTS OFFERED
TABLE 116 AKER BIOMARINE: PRODUCTS OFFERED
TABLE 117 AKER BIOMARINE.: KEY DEVELOPMENTS
TABLE 118 PHARMAMAR: PRODUCTS OFFERED
TABLE 119 PHARMAMAR: KEY DEVELOPMENTS
TABLE 120 CYANOTECH CORPORATION: PRODUCTS OFFERED
TABLE 121 CYANOTECH CORPORATION: KEY DEVELOPMENTS
TABLE 122 ADM: PRODUCTS OFFERED
TABLE 123 GEOMARINE BIOTECHNOLOGIES: PRODUCTS OFFERED
TABLE 124 CP KELCO U.S., INC.: PRODUCT OFFERED
TABLE 125 TERSERA THERAPEUTICS LLC: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL BLUE BIOTECHNOLOGY MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BLUE BIOTECHNOLOGY MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: INDIA CELL CULTURE MEDIA MARKET
FIGURE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY PRODUCT, 2023
FIGURE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY APPLICATION, 2023
FIGURE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, END USER SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY END USER, 2023
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 18 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 20 EUROPE MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 21 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 EUROPE: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 24 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 26 REST OF THE WORLD MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 27 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
FIGURE 31 BLUE BIOTECHNOLOGY MARKET: COMPETITIVE LANDSCAPE
FIGURE 32 MAJOR PLAYERS SALES (USD MILLION), 2023
FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2023
FIGURE 34 MARINOMED BIOTECH AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 MARINOVA: SWOT ANALYSIS
FIGURE 36 AKER BIOMARINE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 AKER BIOMARINE: SWOT ANALYSIS
FIGURE 38 PHARMAMAR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 PHARMAMAR: SWOT ANALYSIS
FIGURE 40 CYANOTECH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ADM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 ADM: SWOT ANALYSIS
FIGURE 43 TERSERA THERAPEUTICS LLC: SWOT ANALYSIS
